- Home
- BIVI vs EQS Comparison
BIVI vs EQS Comparison
Compare BIVI & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- EQS
- Stock Information
- Founded
- BIVI 2013
- EQS 1991
- Country
- BIVI United States
- EQS United States
- Employees
- BIVI N/A
- EQS N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- BIVI Health Care
- EQS Finance
- Exchange
- BIVI Nasdaq
- EQS Nasdaq
- Market Cap
- BIVI 15.1M
- EQS 13.9M
- IPO Year
- BIVI N/A
- EQS N/A
- Fundamental
- Price
- BIVI $1.09
- EQS $0.85
- Analyst Decision
- BIVI Strong Buy
- EQS
- Analyst Count
- BIVI 1
- EQS 0
- Target Price
- BIVI $30.00
- EQS N/A
- AVG Volume (30 Days)
- BIVI 821.9K
- EQS 5.3K
- Earning Date
- BIVI 05-12-2025
- EQS 01-01-0001
- Dividend Yield
- BIVI N/A
- EQS N/A
- EPS Growth
- BIVI N/A
- EQS N/A
- EPS
- BIVI N/A
- EQS N/A
- Revenue
- BIVI N/A
- EQS $1,274,000.00
- Revenue This Year
- BIVI N/A
- EQS N/A
- Revenue Next Year
- BIVI N/A
- EQS N/A
- P/E Ratio
- BIVI N/A
- EQS N/A
- Revenue Growth
- BIVI N/A
- EQS 411.65
- 52 Week Low
- BIVI $0.62
- EQS $0.87
- 52 Week High
- BIVI $7.50
- EQS $1.53
- Technical
- Relative Strength Index (RSI)
- BIVI 54.63
- EQS 37.57
- Support Level
- BIVI $1.05
- EQS $0.74
- Resistance Level
- BIVI $1.29
- EQS $1.01
- Average True Range (ATR)
- BIVI 0.14
- EQS 0.05
- MACD
- BIVI 0.03
- EQS -0.01
- Stochastic Oscillator
- BIVI 56.18
- EQS 33.94
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.